Cipla Ltd (Cipla) is a pharmaceutical company, which manufactures and distributes branded medicines, generics and active pharmaceutical ingredients (APIs). It offers products in therapeutic areas such as cardiovascular and pediatric diseases, dermatological and cosmetological conditions, HIV/AIDS, diabetes, hepatitis, infectious diseases and critical care, neurological, ophthalmic, cancer, malaria, respiratory and urological conditions, osteoporosis and women's health. The company also operates in consumer healthcare and biosimilar businesses. Cipla manufactures metered-dose inhaler devices, spacers and related devices; and conducts R&D to develop new medicines and drug delivery systems. The company has operations in India, US, Canada, South Africa and major regulated and emerging markets among others. Cipla is headquartered in Mumbai, Maharashtra, India.
Headquarters
India
Address
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai, Maharashtra, 400013
Website
www.cipla.com
Telephone
91 22 24826000
No of Employees
21,891
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
CIPLA (NSE)
Revenue (2023)
$2.9B
13.6%
(2023 vs 2022)
EPS
XXX
Net Income (2023)
XXX
4.7%
(2023 vs 2022)
Market Cap*
$10.1B
Net Profit Margin (2023)
XXX
-7.9%
(2023 vs 2022)
* As of and is in US$
Access premium data and analytics for Cipla Ltd
Products and Services
| Products |
|---|
| Drugs and Therapies: |
| Cardiovascular |
| Dermatology and Cosmetology |
| XXX |
| XXX |
| XXX |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2022 | Contracts/Agreements | In December, Cipla (EU) Limited entered into agreements for an investment of EUR15 million in Ethris GmbH. |
| 2022 | New Products/Services | In November, the company launched Leuprolide Acetate Injection Depot 22.5mg. |
| 2022 | Contracts/Agreements | In July, the company signed an agreement for the acquisition of Endura Mass from Medinnbelle Herbalcare. |
Competitor Comparison
| Key Parameters | Cipla Ltd | Sun Pharmaceutical Industries Ltd | Aurobindo Pharma Ltd | Dr. Reddy's Laboratories Ltd | Lupin Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Mumbai | Mumbai | Hyderabad | Hyderabad | Mumbai |
| State/Province | Maharashtra | - | Telangana | - | - |
| No. of Employees | 21,891 | 38,000 | 21,000 | 20,122 | 19,789 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Umang Vohra | Director; Managing Director; Chief Executive Officer - Global | Executive Board | 2016 | - |
| Yusuf K Hamied, Ph.D. | Chairman - Non-Executive | Executive Board | 2013 | - |
| Raju Mistry | President; Chief People Officer | Senior Management | 2019 | - |
| Pradeep Bhadauria | President; Chief Scientific Officer - Global | Senior Management | 2020 | - |
| Geena Malhotra | Chief Technology Officer - Global | Senior Management | 2020 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XX |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company Analytics
Contact the team or request a demo to find out how our data can drive your business forward